Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Gene Therapy

• Publication date

  1995-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7719931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis

  1994cited by this paper
• A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family.

  1994cited by this paper
• Viral vector systems for gene therapy.

  1994cited by this paper
• Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes

  1993cited by this paper
• Human gene therapy.

  1993cited by this paper
• Infection of Human Cells with Murine Amphotropic Replication-Competent Retroviruses

  1993cited by this paper
• Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

  1993cited by this paper
• Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

  1992cited by this paper
• Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor

  1991cited by this paper
• Retrovirus Packaging Cells

  1990cited by this paper
• Construction and use of a safe and efficient amphotropic packaging cell line.

  1988cited by this paper
• Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human.

  1987cited by this paper
• Isolation from cats of an endogenous type C virus with a novel envelope glycoprotein

  1985cited by this paper
• Recombination events after transient infection and stable integration of DNA into mouse cells

  1985cited by this paper
• Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene

  1985cited by this paper
• A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ectropic, amphotropic, xenotropic, and mink cell focus-forming viruses

  1984cited by this paper
• Genomes of murine leukemia viruses isolated from wild mice

  1981cited by this paper
• An in vitro focus-induction assay for xenotropic murine leukemia virus, feline leukemia virus C, and the feline--primate viruses RD-114/CCC/M-7.

  1975cited by this paper
• Plaque assay techniques for murine leukemia viruses.

  1970cited by this paper

• Risks of replication-competent retro/lentivirus from associated vector systems: Is it time for a roadmap toward reduced testing?

  2025cites this paper
• Quality Control and Nonclinical Research on CAR-T Cell Products: General Principles and Key Issues

  2019cites this paper
• Biosafety in Handling Gene Transfer Vectors

  2018cites this paper
• Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience

  2018cites this paper
• Production of Transgenic Nonhuman Primates

  2014cites this paper
• A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay

  2012cites this paper
• General principles of retrovirus vector design.

  2012cites this paper
• Detection of replication competent retrovirus and lentivirus.

  2009cites this paper
• Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

  2008cites this paper
• Chapter 17 Detection of Replication Competent Retrovirus and Lentivirus

  2008cites this paper
• Purification of retroviral vectors for clinical application: biological implications and technological challenges.

  2007cites this paper
• A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors

  2006cites this paper
• Lentiviral vectors.

  2005cites this paper
• Product-Enhanced Reverse Transcriptase Assay for Replication-Competent Retrovirus and Lentivirus Detection

  2005cites this paper
• Retroviral vector production in the National Gene Vector Laboratory at Indiana University

  2005cites this paper
• Development of enzyme-linked immunosorbent assay for detecting antibodies to replication-competent murine leukemia virus.

  2004cites this paper
• An improved method for detection of replication-competent retrovirus in retrovirus vector products.

  2004cites this paper
• Generation of retroviral packaging and producer cell lines for large-scale vector production with improved safety and titer.

  2003cites this paper
• Characterization and detection of artificial replication-competent lentivirus of altered host range.

  2003cites this paper
• Retrovectors Go Forward

  2003cites this paper
• LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

  2003cites this paper
• Biosafety in Handling Gene Transfer Vectors

  2002cites this paper
• Detection of Ecotropic Replication-Competent Retroviruses: Comparison of S+/L- and Marker Rescue Assays

  2002cites this paper
• Biosafety in Handling Gene Transfer Vectors

  2002cites this paper
• CHAPTER 14 – Production of Transgenic Nonhuman Primates

  2002cites this paper
• Brief Report Detection of Ecotropic Replication-Competent Retroviruses: Comparison of S 1 /L 2 and Marker Rescue Assays

  2002cites this paper
• Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.

  2001cites this paper
• Safety Testing for Replication-Competent Retrovirus Associated with Gibbon Ape Leukemia Virus-Pseudotyped Retroviral Vectors

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• The use and development of retroviral vectors to deliver cytokine genes for cancer therapy.

  2000cites this paper
• Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer.

  2000cites this paper
• Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

  2000cites this paper
• Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy.

  1999cites this paper
• Effects of Keratinocyte and Hepatocyte Growth Factor In Vivo: Implications for Retrovirus-Mediated Gene Transfer to Liver

  1998cites this paper
• Human immunodeficiency virus immunotherapy using a retroviral vector.

  1998cites this paper
• Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.

  1998cites this paper
• DNA Vaccination/Genetic Vaccination

  1998cites this paper
• Evaluation of Recommendations for Replication-Competent Retrovirus Testing Associated with Use of Retroviral Vectors

  1997influential citation
• Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer

  1997cites this paper
• Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes.

  1996cites this paper
• A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety.

  1996cites this paper
• Improved detection of replication-competent retrovirus.

  1996cites this paper
• Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.

  1996cites this paper
• Gene delivery systems for use in gene therapy: an overview of quality assurance and safety issues.

  1996cites this paper
• Retroviral Vectors for HIV Immunotherapy

  1995cites this paper